Maravai LifeSciences Holdings Sees FY24 $265M-$285M Vs $275.443M Est.
Portfolio Pulse from Benzinga Newsdesk
Maravai LifeSciences Holdings has provided its financial guidance for FY24, expecting revenues between $265 million and $285 million, compared to the analyst estimate of $275.443 million.
August 07, 2024 | 9:54 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Maravai LifeSciences Holdings has issued its revenue guidance for FY24, projecting between $265 million and $285 million, which is slightly above the analyst estimate of $275.443 million.
The revenue guidance provided by Maravai LifeSciences Holdings is slightly above the analyst estimate, which is likely to be viewed positively by investors. This could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100